Helicobacter pylori and atherosclerosis. A review of the literature;Infezione da Helicobacter pylori e aterosclerosi. Una revisione dei dati della letteratura

Recenti Progressi in Medicina

Volumn 100, Issue 2, 2009, Pages 91-96

  Franceschi, Francesco ^a   Navarese, Eliano Pio ^a   Mollo, Roberto ^a   Giupponi, Bianca ^a   De Marco, Guido ^a   Merra, Giuseppe ^a   Gasbarrini, Giovanni ^a   Silveri, Nicolo Gentiloni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atherosclerosis; Helicobacter pylori; Ischemic heart disease

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ATHEROSCLEROSIS; BACTERIAL PROTEINS; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; HEAT-SHOCK PROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RISK FACTORS; TUNICA INTIMA;

EID: 62449254029     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Majka J, Rog T, Konturek PC, Konturek SJ, Bielanski W, Kowalsky M, et al. Influence of chronic Helicobacter pylori infection on ischaemic cerebral stroke risk factors. Med Sci Monit 2002; 8: CR675-84.
2. Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999; 50: 743-51.
3. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001; 52 (1 suppl 1): 3-31.
4. Pellicano R, Broutet N, Ponzetto A, Mégraud F. Helicobacter pylori: from the stomach to the heart. Eur J Gastroenterol-Hepatol 1999; 11: 1335-7.
5. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 573-5
6. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat schock protein 65 and coronary atherosclerosis. Possible mechanism of action of "Helicobacter pylori" and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998; 19: 387-94.
7. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106: 430-4.
8. Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, et al. CagA antigen of helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis (in corso di pubblica- zione).
9. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 43-79.
10. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999; 319(7218): 1157-62.
11. Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 2002; 88: 43-6.
12. Yoshikawa H, Aida K, Mori A, Muto S, Fukuda T. Involvement of Helicobacter pylori infection and impaired glucose metabolism in the increase of brachial-ankle pulse wave velocity. Helicobacter 2007 Oct; 12(5): 559-66.
13. Hamed SA, Amine NF, Galal GM, Helal SR, Tag El- Din LM, Shawky OA, et al. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008; 17(2): 86-94.
14. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 1997; 315: 1199-1201.
15. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999; 100: 2326-31.
16. Stone AF, Risley P, Markus HS, Butland BK, Strachan DP, Elwood PC, et al. Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study. Heart 2001; 86: 506-9.
17. Hagiwara N, Toyoda K, Inoue T, Shimada H, Ibayashi S, Iida M, et al. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis 2007; 16: 145-52.
18. Rizzo M, Corrado E, Coppola G, Muratori I, Novo S. Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. J Investig Med 2008; 56: 32-40.
19. Stone AF, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and unstable Angina (STAMINA). Circulation 2002; 106: 1219-23.
20. Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by 13C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000; 97: 411-20.